订阅小程序
旧版功能

A Phase 1b/2 Study Evaluating Efficacy and Safety of MP0250, a Designed Ankyrin Repeat Protein (darpin) Simultaneously Targeting Vascular Endothelial Growth Factor (VEGF) and Hepatocyte Growth Factor (HGF), in Combination with Bortezomib and Dexamethasone, in Patients with Relapsed or Refractory Multiple Myeloma

Stefan Knop,Monika Szarejko,Norbert Grzasko,Sara Bringhen,Karolin Trautmann-Grill,Artur Jurczyszyn,Angelo Vacca,Cyrus Khandanpour,Barbara Gamberi,Ludek Pour,Katrine F. Iversen,Michael T. Stumpp, Cosima Suter,Keith M. Dawson,Christof Zitt,Philippe Legenne,Vaia Stavropoulou,Martin F. Fey,Nicolas Leupin,Hartmut Goldschmidt

EJHAEM（2024）

引用 0|浏览9
关键词
anti-HGF,anti-VEGF,DARPin,MP0250,refractory/relapsed multiple myeloma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要